Further information The panel agreed the technology is not appropriate to be selected for guidance development as there is insufficient evidence. For further information on how we select topics for ...

Ambu has obtained 510(k) regulatory clearance from the US Food and Drug Administration (FDA) for its new-generation duodenoscopy solution, the aScope Duodeno 2 and aBox 2, which is designed for ...

Ambu AS (AMBFF) reports robust Q1 performance with significant growth in Endoscopy Solutions and upgraded financial guidance.